Multidrug-resistant tuberculosis, Somalia, 2010-2011

Emerging Infectious Diseases

Volumn 19, Issue 3, 2013, Pages 478-480

  Sindani, Ireneaus ^a   Fitzpatrick, Christopher ^a   Falzon, Dennis ^a   Suleiman, Bashir ^a   Arube, Peter ^b   Adam, Ismail ^c   Baghdadi, Samiha ^a   Bassili, Amal ^a   Zignol, Matteo ^a  

^a WORLD HEALTH ORGANIZATION   (Switzerland)

^b WORLD VISION INTERNATIONAL   (Kenya)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

ISONIAZID; RIFAMPICIN;

ADULT; AFRICA; AGED; ARTICLE; CHILD; FEMALE; HEALTH SURVEY; HUMAN; INFECTION CONTROL; MAJOR CLINICAL STUDY; MALE; MIDDLE EAST; MULTIDRUG RESISTANCE; MULTIDRUG RESISTANT TUBERCULOSIS; PRESCHOOL CHILD; PREVALENCE; QUESTIONNAIRE; SOMALIA;

DRUG RESISTANCE; MYCOBACTERIUM TUBERCULOSIS AND OTHER MYCOBACTERIA; SOMALIA; SURVEILLANCE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; EPIDEMIOLOGICAL MONITORING; FEMALE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; PREVALENCE; SOMALIA; TUBERCULOSIS, MULTIDRUG-RESISTANT; TUBERCULOSIS, PULMONARY; YOUNG ADULT;

EID: 84874226125     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid1903.121287     Document Type: Article

References (15)

1. United Nations Development Program. Human development report 2011. New York: The Program; 2011.
2. The Fund for Peace. 2012 Country profile of Somalia. Washington (DC): The Fund; 2012.
3. World Health Organization. Global health observatory. Data repository [cited 2012 Oct 12]. http://www.who.int/gho/database/en
4. World Health Organization. Global tuberculosis report 2012 (WHO/HTM/TB/2012.6). Geneva: The Organization; 2012.
5. World Health Organization. Guidelines for surveillance of drug resistance in tuberculosis. 4th ed. (WHO/HTM/TB/2009.422). Geneva: The Organization; 2009.
6. World Health Organization. Treatment of tuberculosis: guidelines. 4th ed. (WHO/HTM/TB/2009.420). Geneva: The Organization; 2009.
7. Ling DI, Zwerling AA, Pai M. GenoType MTBDR assays for the diagnosis of multidrug-resistant tuberculosis: a meta-analysis. Eur Respir J. 2008;32:1165-74. http://dx.doi.org/10.1183/09031936.00061808
8. Barnard M, Albert H, Coetzee G, O'Brien R, Bosman ME. Rapid molecular screening for multidrug-resistant tuberculosis in a high-volume public health laboratory in South Africa. Am J Respir Crit Care Med. 2008;177:787-92. http://dx.doi.org/10.1164/rccm.200709-1436OC
9. Wright A, Zignol M, Van Deun A, Falzon D, Gerdes SR, Feldman K, et al. Global Project on Anti-tuberculosis Drug Resistance Surveillance. Epidemiology of antituberculosis drug resistance 2002-07: an updated analysis of the Global Project on Anti-tuberculosis Drug Resistance Surveillance. Lancet. 2009;373:1861-73. http://dx.doi.org/10.1016/S0140-6736(09)60331-7
10. World Health Organization. Anti-tuberculosis drug resistance in the world: fourth global report. (WHO/HTM/TB/2008.394). Geneva: The Organization; 2008.
11. Falzon D, Jaramillo E, Schünemann H, Arentz M, Bayona J, Blanc L, et al. WHO guidelines for the programmatic management of drug-resistant tuberculosis: 2011 update. Eur Respir J. 2011;38:516-28. http://dx.doi.org/10.1183/09031936.00073611
12. World Health Organization. Guidelines for the programmatic management of drug-resistant tuberculosis. 2011 update (WHO/HTM/TB/2011.6). Geneva: The Organization; 2011.
13. Fitzpatrick C, Floyd K. A systematic review of the cost and cost effectiveness of treatment for multidrug-resistant tuberculosis. Pharmacoeconomics. 2012;30:63-80. http://dx.doi.org/10.2165/11595340-000000000-00000
14. United Nations Office for the Coordination of Humanitarian Affairs [cited 2012 Oct 24]. http://ochaonline.un.org/OchaLinkClick.aspx?link=ocha&docId=1270867
15. The United Nations Refugee Agency [cited 2012 Oct 24]. http://ochaonline.un.org/OchaLinkClick.aspx?link=ocha&docId=1337858